SHPAX
Price
$19.13
Change
+$0.23 (+1.22%)
Updated
Jun 24 closing price
Net Assets
9.98M
VGHCX
Price
$173.23
Change
+$2.16 (+1.26%)
Updated
Jun 24 closing price
Net Assets
36.03B
Interact to see
Advertisement

SHPAX vs VGHCX

Header iconSHPAX vs VGHCX Comparison
Open Charts SHPAX vs VGHCXBanner chart's image
Saratoga Health & Biotechnology A
Price$19.13
Change+$0.23 (+1.22%)
VolumeN/A
Net Assets9.98M
Vanguard Health Care I
Price$173.23
Change+$2.16 (+1.26%)
VolumeN/A
Net Assets36.03B
SHPAX vs VGHCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SHPAX vs. VGHCX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHPAX is a Buy and VGHCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 36B vs. SHPAX (9.98M). VGHCX pays higher dividends than SHPAX: VGHCX (0.89) vs SHPAX (0.00). SHPAX was incepted earlier than VGHCX: SHPAX (26 years) vs VGHCX (41 years). SHPAX (2.72) is less costly to investors than VGHCX (0.37). VGHCX is a more actively managed with annual turnover of: 29.00 vs. SHPAX (17.00). SHPAX has a lower initial minimum investment than VGHCX: SHPAX (250) vs VGHCX (3000). SHPAX annual gain was more profitable for investors over the last year : -6.90 vs. VGHCX (-21.82). SHPAX return over 5 years is better than : -3.72 vs. VGHCX (-17.57).
SHPAXVGHCXSHPAX / VGHCX
Total Expense Ratio2.720.37735%
Annual Report Gross Expense Ratio2.720.37735%
Fund Existence26 years41 years-
Gain YTD0.585-6.196-9%
Front Load6%N/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets9.98M36B0%
Annual Yield % from dividends0.000.89-
Returns for 1 year-6.90-21.8232%
Returns for 3 years-4.55-14.5931%
Returns for 5 years-3.72-17.5721%
Returns for 10 years-41.07-27.57149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDERX22.640.01
+0.06%
Federated Hermes Equity Income R
GQLOX33.90N/A
N/A
GMO Quality VI
MDOEX11.02N/A
N/A
Morgan Stanley Developing Opportunity I
UGLSX75.03N/A
N/A
JHancock U.S. Global Leaders Growth R6
MSCFX27.48N/A
N/A
Mairs & Power Small Cap